Quality comparison between two different types of platelet-rich plasma for knee osteoarthritis

Takanori Wakayama; Yoshitomo Saita; Yohei Kobayashi; Hirofumi Nishio; Sayuri Uchino; Shin Fukusato; Hiroshi Ikeda; Kazuo Kaneko

doi:10.1051/rmr/200002

All issues

Volume 8 (2020)

Regen Med Res, 8 (2020) 3

Full HTML

Open Access

Table 2

Leukocyte concentration and composition in whole blood (WB), LP-PRP, and APS.

PRPs and Blood components	Healthy volunteers (HV)				Knee osteoarthritis (KOA)
	Leukocyte concentration (×10³/ml)	Cell counts (×10³/ml) and composition (%)			Leukocyte concentration (×10³/ml)	Cell counts (×10³ /ml) and composition (%)
	Leukocyte concentration (×10³/ml)	Lymphocyte	Monocyte	Neutrophil	Leukocyte concentration (×10³/ml)	Lymphocyte	Monocyte	Neutrophil
Whole blood	4.3 ± 1.1	1.4 ± 0.3 (33.3 ± 8.4)	0.2 ± 0.09 (5.9 ± 2.0)	2.7 ± 1.1 (60.7 ± 9.0)	5.9 ± 1.0	1.7 ± 0.3 (29.2 ± 4.7)	0.3 ± 0.1 (6.5 ± 2.5)	3.8 ± 0.8 (64.2 ± 4.1)
LP-PRP	1.9 ± 0.8	1.7 ± 0.7 (89.7 ± 3.0)	0.1 ± 0.06 (5.4 ± 2.8)	0.08 ± 0.09 (3.7 ± 2.9)	2.4 ± 1.1	2.3 ± 0.8 (84.8 ± 5.4)	0.2 ± 0.1 (7.5 ± 6.5)	0.2 ± 0.2 (7.5 ± 4.7)
APS	44.1 ± 7.5	20.6 ± 3.2 (47.9 ± 10.7)	5.0 ± 3.2 (11.8 ± 8.0)	18.4 ± 9.4 (40.1 ± 14.8)	26.6 ± 10.5	13.1 ± 3.8 (52.1 ± 15.3)	2.4 ± 1.1 (9.2 ± 2.7)	11.1 ± 7.0 (38.5 ± 16.1)

Data are presented as the mean ± SD. LP-PRP, leukocyte-poor platelet-rich plasma; APS, autologous protein solution.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.